Abstract Body

Persistent inflammation and immune dysregulation can contribute to cardiovascular disease (CVD) risk in patients with chronic HIV infection. 

We conducted a longitudinal analysis utilizing HIV-infected subjects on stable antiretroviral therapy (ART) in the Hawaii Aging with HIV-Cardiovascular (HAHC-CVD) study to determine the correlation of peripheral monocyte subsets and biomarkers of inflammation to progression of atherosclerosis using 2 year change in carotid artery intima-media thickness (CIMT) and coronary artery calcium (CAC). Peripheral blood mononuclear cells (PBMC) were immunophenotyped by multiparametric flow cytometry to quantify classical (CD14++CD16–), intermediate (CD14++CD16+), non-classical (CD14low/+CD16++) and transitional (CD14+CD16–) monocyte subsets. Biomarkers (sE-selectin, sVCAM-1, sICAM-1, MMP-9, tPA-1, hsCRP, IL-6, IL-8, IL-10, TNF-α, MCP-1, IFN-α) were assessed by multiplex Luminex assay. The primary outcome variables were change in CIMT (right common carotid artery (CCA) and bifurcation (BIF)) and CAC over 2 years.

105 subjects: 91% male, median age 51 (Q1, Q3; 47, 57) years, median CD4 count 491 (352, 660) cells/mm3, and 87% with HIV RNA<50 copies/mL. The rate of change in CCA, BIF, and CAC was 0.010 mm/year, 0.0097 mm/year, and 16.2 Agatston units/year, respectively. Change in CCA correlated with TNFα (r= – 0.28, p=0.026) but not with any monocyte subset. Change in BIF correlated with non-classical monocytes (r=0.29, p=0.038) and  MCP-1 (r=0.34, p=0.005). Change in CAC correlated with non-classical monocytes (r=0.27, p=0.015) and MCP-1 (r=0.46, p<0.001). Non-classical monocyte and MCP-1 remained significantly associated with CAC and BIF progression after adjustment for age, hypertension, diabetes mellitus, total/HDL cholesterol ratio, and smoking history. 

Non-classical monocytes and  MCP-1 were associated with progression of atherosclerosis. The role of monocyte subsets in atherosclerosis warrants further investigation.